Pembrolizumab-Induced Type 1 Diabetes in a 95-Year-Old Veteran With Metastatic Melanoma

Damond B Ng; Jane Weinreb; Sara-Megumi Rumrill

doi:10.12788/fp.0191

Pembrolizumab-Induced Type 1 Diabetes in a 95-Year-Old Veteran With Metastatic Melanoma

Fed Pract. 2021 Nov;38(11):520-523. doi: 10.12788/fp.0191.

Authors

Damond B Ng¹, Jane Weinreb^{1

2}, Sara-Megumi Rumrill^{3

4}

Affiliations

¹ Department of Medicine, David Geffen School of Medicine, Los Angeles, California.
² Veterans Affairs Greater Los Angeles Healthcare System, California.
³ San Francisco Veterans Affairs Medical Center, California.
⁴ Department of Medicine, University of California, San Francisco.

Abstract

Low C-peptide levels should prompt a high suspicion for immune checkpoint inhibitor-induced type 1 diabetes, and initiation of insulin therapy should be strongly considered.